OrbusNeich Medical Group Holdings Limited

SEHK:6929 주식 보고서

시가총액: HK$3.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

OrbusNeich Medical Group Holdings 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

David Chien

최고 경영자

US$1.0m

총 보상

CEO 급여 비율79.8%
CEO 임기7.8yrs
CEO 소유권n/a
경영진 평균 재임 기간5.7yrs
이사회 평균 재임 기간3yrs

최근 관리 업데이트

Recent updates

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

Jul 19
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%

OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jul 03
OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

May 28
Is OrbusNeich Medical Group Holdings (HKG:6929) A Risky Investment?

Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

May 06
Optimistic Investors Push OrbusNeich Medical Group Holdings Limited (HKG:6929) Shares Up 27% But Growth Is Lacking

OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Apr 25
OrbusNeich Medical Group Holdings' (HKG:6929) Earnings Are Weaker Than They Seem

Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Mar 13
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 26%

Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

Feb 04
Returns At OrbusNeich Medical Group Holdings (HKG:6929) Appear To Be Weighed Down

A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Oct 20
A Look At The Intrinsic Value Of OrbusNeich Medical Group Holdings Limited (HKG:6929)

Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

Jun 01
Some OrbusNeich Medical Group Holdings Limited (HKG:6929) Shareholders Look For Exit As Shares Take 28% Pounding

CEO 보상 분석

David Chien 의 보수는 OrbusNeich Medical Group Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$39m

Mar 31 2024n/an/a

US$42m

Dec 31 2023US$1mUS$808k

US$45m

Sep 30 2023n/an/a

US$40m

Jun 30 2023n/an/a

US$36m

Mar 31 2023n/an/a

US$27m

Dec 31 2022US$1mUS$769k

US$18m

Sep 30 2022n/an/a

US$9m

Jun 30 2022n/an/a

US$272k

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$355kUS$326k

-US$4m

Dec 31 2020US$335kUS$320k

US$7m

Dec 31 2019US$336kUS$308k

US$7m

보상 대 시장: David 의 총 보상 ($USD 1.01M )은 Hong Kong 시장( $USD 358.97K ).

보상과 수익: David 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

David Chien (59 yo)

7.8yrs

테뉴어

US$1,012,000

보상

Mr. David Chien serves as Chairman of the Board of OrbusNeich Medical Group Holdings Limited and serves as its Chief Executive Officer since November 11, 2016. Mr. Chen has served as Director of OrbusNeic...


리더십 팀

이름위치테뉴어보상소유권
David Chien
Chairman of the Board & CEO7.8yrsUS$1.01m데이터 없음
Wing Shing Chen
CFO, Company Secretary & Executive Director6.7yrsUS$569.00k데이터 없음
Kwai Ching Lau
COO & Executive Director4yrsUS$702.00k데이터 없음
Alain Djamel Khair
Chief Commercial Officer4.7yrs데이터 없음데이터 없음

5.7yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: 6929 의 관리팀은 노련하고 경험 (평균 재직 기간 5.1 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
David Chien
Chairman of the Board & CEO3.2yrsUS$1.01m데이터 없음
Wing Shing Chen
CFO, Company Secretary & Executive Director3.2yrsUS$569.00k데이터 없음
Kwai Ching Lau
COO & Executive Director3.2yrsUS$702.00k데이터 없음
Yip Keung Chan
Independent Non-Executive Director3yrsUS$31.00k데이터 없음
Yi Zhou
Non-Executive Director3yrs데이터 없음데이터 없음
Ka Keung Lau
Independent Non-Executive Director3yrsUS$31.00k데이터 없음
Lai Fan Tam
Independent Non-Executive Director3yrsUS$31.00k데이터 없음
Ching Chung Chow
Non-Executive Director3.2yrsUS$279.94k0.037%
$ 1.1m
Ting San Leung
Non-Executive Director1.3yrsUS$19.00k데이터 없음

3.0yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 이사회: 6929 의 이사회경험(평균 재직 기간 3 년)으로 간주됩니다.